Risk Assessment of Medication-Regimen Complexity During Transitions Between Healthcare Settings

Abstract

Transitions between healthcare settings such as hospital admission, transfer to rehabilitation, or discharge to home are periods of heightened vulnerability for patients, particularly concerning medication safety. Medication-regimen complexity, characterized by the number, diversity, and administration requirements of prescribed drugs, has emerged as a crucial determinant of adverse drug events (ADEs), medication errors, and poor adherence during these transitions. This review synthesizes current evidence regarding the assessment of medication-regimen complexity, its clinical consequences, and strategies for risk mitigation in transitional care. Emphasis is placed on validated assessment tools, pathophysiological mechanisms underpinning regimen complexity-related risks, and emerging approaches to streamline pharmacotherapy for improved patient outcomes.

Introduction

Medication management during transitions of care presents significant challenges for clinicians. The complexity of medication regimens often escalates as patients move between different settings, such as from hospital to home or to long-term care facilities. These transitions are associated with increased risk of medication discrepancies, non-adherence, and preventable adverse drug events. Understanding, assessing, and mitigating medication-regimen complexity is paramount for patient safety, optimal therapeutic outcomes, and efficient healthcare delivery. This article reviews the burden, mechanisms, and clinical implications of medication-regimen complexity during transitions, guiding clinicians toward evidence-based strategies for risk assessment and intervention.

Epidemiology / Disease Burden

The prevalence of complex medication regimens is rising with the aging population and increasing multimorbidity. Studies indicate that over 60% of hospitalized elderly patients are prescribed five or more medications at discharge, with 20-30% experiencing medication discrepancies. Medication-regimen complexity is independently associated with higher rates of hospital readmission and ADEs one meta-analysis estimated that 30% of hospital readmissions within 30 days are medication-related, with regimen complexity as a significant predictor. The burden is particularly pronounced in patients with heart failure, diabetes, and polypharmacy, where transitions amplify the risk of errors. Healthcare systems globally face significant financial and quality-of-care challenges due to these adverse outcomes.

Pathophysiology

The pathophysiological impact of medication-regimen complexity stems from the cognitive, behavioral, and pharmacokinetic demands imposed on patients and providers. Complex regimens often involve multiple dosing schedules, diverse administration routes, and intricate monitoring requirements. This complexity increases the risk of forgotten doses, incorrect administration, and drug-drug interactions. Mechanistically, polypharmacy and regimen intricacy can disrupt pharmacodynamics, heighten the potential for cumulative toxicity, and precipitate adverse interactions especially in populations with reduced renal or hepatic function. These mechanisms underscore the importance of regimen simplification and individualized pharmacotherapy during transitions.

Risk Factors

Several patient- and system-level factors contribute to elevated risk associated with medication-regimen complexity. Patient-level factors include advanced age, cognitive impairment, low health literacy, multiple chronic diseases, and limited social support. System-level contributors encompass fragmented care, inadequate communication between providers, and lack of standardized medication reconciliation processes. High-risk transitions include those involving intensive care units, surgical services, and long-term care settings. Additionally, the use of high-alert medications (e.g., anticoagulants, insulin) and frequent changes to therapy amplify the potential for regimen-related adverse outcomes.

Clinical Features

Clinically, medication-regimen complexity manifests as increased risk of medication errors, decreased adherence, and higher incidence of ADEs. Common features observed during transitions include unintentional medication omissions, duplications, dosing errors, and patient confusion regarding new or discontinued therapies. These issues may present as acute decompensation of chronic diseases, unexplained symptoms, or hospital readmission. In vulnerable populations, such as the elderly or those with cognitive deficits, the clinical impact is often more pronounced, resulting in functional decline and increased morbidity.

Diagnosis

Assessment of medication-regimen complexity involves both quantitative and qualitative approaches. The Medication Regimen Complexity Index (MRCI) is the most validated tool, incorporating factors such as dosage forms, dosing frequency, and additional directions. Comprehensive medication reconciliation at each transition point is essential for identifying discrepancies and potential sources of complexity. Clinical pharmacists play a pivotal role in regimen assessment, utilizing structured interviews, chart reviews, and patient engagement to ensure accuracy and appropriateness of prescribed therapies.

Treatment & Management

Effective management strategies focus on reducing unnecessary regimen complexity and enhancing communication across care settings. Interventions include deprescribing of non-essential medications, consolidating dosing schedules, and employing fixed-dose combination products where appropriate. Multidisciplinary care teams, featuring pharmacists, nurses, and physicians, are integral for coordinated medication reconciliation and patient education. Tailored discharge planning, clear written instructions, and post-discharge follow-up further mitigate risk. Engaging patients and caregivers in shared decision-making fosters adherence and empowers self-management.

Recent Advances / Emerging Therapies

Recent innovations center on health information technology and clinical decision support systems (CDSS). Electronic health records with integrated medication reconciliation modules facilitate real-time identification of regimen complexity and discrepancies. Mobile health applications and digital pill organizers offer patient-centered solutions to simplify adherence. Emerging research explores the use of artificial intelligence to predict high-risk transitions and automate deprescribing recommendations. Additionally, novel pharmacological formulations, such as extended-release and combination therapies, are being developed to streamline complex regimens.

Guideline Recommendations

Multiple organizations, including the Institute for Healthcare Improvement (IHI) and the American Geriatrics Society (AGS), advocate for standardized medication reconciliation at every transition. Guidelines recommend routine assessment of medication-regimen complexity using validated tools like the MRCI, especially in older adults and those with multiple comorbidities. Best practices emphasize interprofessional communication, patient engagement, and individualized deprescribing. Regular review of medication lists, prioritization of evidence-based therapies, and alignment with patient goals are central to guideline-concordant care during transitions.

Conclusion

Medication-regimen complexity is a critical, yet modifiable, risk factor for adverse outcomes during transitions between healthcare settings. Proactive assessment, simplification of regimens, and multidisciplinary collaboration are essential strategies to reduce errors and enhance patient safety. Ongoing research and integration of digital health innovations promise to further optimize medication management during these vulnerable periods. Clinicians must remain vigilant in identifying at-risk patients and implementing evidence-based interventions to improve transitional care and long-term outcomes.